Variable | N | Total | Good outcome | Poor outcome | p Value |
---|---|---|---|---|---|
mRS 0–2 | mRS 3–6 | ||||
Early recan | |||||
Age | 110 | 63.56 (14.51) | 61.92 (14.67) | 66.94 (13.75) | 0.09 |
Female | 110 | 52 (47.3) | 32 (43.2) | 20 (55.6) | 0.225 |
White | 110 | 62 (56.4) | 41 (55.4) | 21 (58.3) | 0.771 |
Baseline NIHSS | 110 | 14.362 (6.94) | 12.49 (5.07) | 19.00 (8.17) | <0.001 |
Onset to groin (hours) | 110 | 8.35 (6.57) | 7.52 (6.22) | 9.96 (7.01) | 0.103 |
IV tPA | 110 | 40 (36.4) | 26 (35.1) | 14 (38.9) | 0.701 |
AF | 110 | 22 (20.0) | 15 (20.3) | 7 (19.4) | 0.919 |
Diabetes | 110 | 22 (20.0) | 18 (24.3) | 4 (11.1) | 0.104 |
Hypertension | 110 | 74 (67.3) | 49 (66.2) | 25 (69.4) | 0.735 |
Recanalization time (min) | 110 | 18.55 (8.37) | 17.93 (7.67) | 19.81 (9.66) | 0.313 |
Final TICI flow | 110 | 0.707 | |||
0 | 1 (0.9) | 1 (1.4) | 0 (0.0) | ||
1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
2a | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
2b | 22 (20.0) | 14 (18.9) | 8 (22.2) | ||
2c | 10 (9.1) | 8 (10.8) | 2 (5.6) | ||
3 | 77 (70.0) | 51 (68.9) | 26 (72.2) | ||
Final TICI flow | 110 | 0.484 | |||
0–2a | 1 (0.9) | 1 (1.35) | 0 (0.0) | ||
2b–3 | 109 (99.1) | 73 (98.6) | 36 (100.0) | ||
Complication | 110 | 2 (1.8) | 0 (0.0) | 2 (5.6) | 0.105 |
Hemorrhage | 110 | 25 (22.7) | 12 (16.2) | 13 (36.1) | 0.019 |
Device: Trevo | 110 | 5 (4.5) | 3 (4.1) | 2 (5.6) | 0.662 |
Device: Solitaire | 110 | 9 (8.2) | 7 (9.5) | 2 (5.6) | 0.715 |
Device: Precise | 110 | 1 (0.9) | 1 (1.4) | 0 (0.0) | 1.00 |
Device: other | 110 | 95 (86.4) | 63 (85.1) | 32 (88.9) | 0.59 |
Delayed recan | |||||
Age | 70 | 70.01 (13.22) | 65.96 (12.84) | 72.41 (12.99) | 0.048 |
Female | 70 | 35 (50.0) | 10 (38.5) | 25 (56.8) | 0.138 |
White | 70 | 43 (61.4) | 16 (61.5) | 27 (61.4) | 0.988 |
Baseline NIHSS | 70 | 15.96 (7.42) | 13.12 (7.38) | 17.36 (6.99) | 0.013 |
Onset to groin (hours) | 70 | 7.03 (5.17) | 6.03 (4.47) | 7.72 (5.56) | 0.241 |
IV tPA | 70 | 22 (31.4) | 11 (42.3) | 11 (25.0) | 0.132 |
AF | 70 | 13 (18.6) | 3 (11.5) | 10 (22.7) | 0.345 |
Diabetes | 70 | 13 (18.6) | 5 (19.2) | 8 (18.2) | 0.913 |
Hypertension | 70 | 32 (45.7) | 8 (30.8) | 24 (54.5) | 0.054 |
Recanalization time (min) | 70 | 68.51 (38.91) | 62.81 (25.30) | 71.89 (45.01) | 0.349 |
Final TICI flow | 70 | 0.299 | |||
0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
1 | 3 (4.3) | 0 (0.0) | 3 (6.8) | ||
2a | 3 (4.3) | 1 (3.8) | 2 (4.5) | ||
2b | 29 (41.4) | 8 (30.8) | 21 (47.7) | ||
2c | 4 (5.7) | 2 (7.7) | 2 (4.5) | ||
3 | 31 (44.3) | 15 (57.7) | 16 (36.4) | ||
Final TICI flow | 70 | 0.269 | |||
0–2a | 6 (8.6) | 1 (3.8) | 5 (11.4) | ||
2b–3 | 64 (91.4) | 25 (96.2) | 39 (88.6) | ||
Complication | 70 | 1 (1.4) | 1 (3.8) | 0 (0.0) | 0.371 |
Hemorrhage | 70 | 29 (41.4) | 10 (38.5) | 19 (43.2) | 0.698 |
Device: Trevo | 70 | 13 (18.6) | 4 (15.4) | 9 (20.5) | 0.424 |
Device: Solitaire | 70 | 18 (25.7) | 8 (30.8) | 10 (22.7) | 0.457 |
Device: Precise | 70 | 8 (11.4) | 4 (15.4) | 4 (0.1) | 0.458 |
Device: other | 70 | 36 (51.4) | 14 (53.8) | 22 (50.0) | 0.756 |
Values are n (%) or mean (SD).
χ2 Test (Fisher's exact test for small cell sizes) or Student's t test for the entire patient cohort.
AF, atrial fibrillation; IV tPA, IV tissue plasminogen activator; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; TICI, Thrombolysis in Cerebral Infarction.